10 BÜCHER, DIE MIT «HEMOFIL» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
hemofil in der folgenden bibliographischen Auswahl. Bücher, die mit
hemofil im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
1
Physicians' Desk Reference
Table 1 In Vitro Virus Clearance During the Manufacture of HEMOFIL M AHF Process Step Evaluated Lipid-enveloped HIV-1 BVD PRV Immunoafiinity Chromatography N.A.** N.A.** N.A.** 4.2 5.3 Cumulative Total, |0910 10.3 6.1 5.4 5.6 7.3 ...
2
Plasma Fractionation and Blood Transfusion: Proceedings of ...
PATIENTS A B C D E F G H K L Mean AHF- Kabi 79 67 68 69 – 71 Octonativ "8 121 89 90 105 97 DDAVP Octonativ 75 104 96 99 126 100 Hemofil 67 86 74 76 Hemofil T 65 78 82 100 81 Profilate 78 79 53 64 69 Profilate HS 110 79 80 84 88 ...
Cees Smit Sibinga, P.C. Das, S. Seidl, 2012
3
Proceedings of the Fifth International Symposium on ... - Sayfa 83
Table 5 Hyland's Hemofil-T. Recovery and Half-Life Data Study Timing No. of Half-Life (hrs) Recovery (%) Patients (Mean ± S.D.) (Mean ± S.D.) Hemofil T 05/82 (Method IV) vs Hemofil (Dr. P. Blatt, Univ. of N. Carolina) Hemofil T 10/82 (Method ...
4
2016 Intravenous Medications: A Handbook for Nurses and ...
Novoeight Recombinate Xyantha Hemofil M 20 to 40 See formula Repeat every 12 to 24 hr for at least 1 day (usually 1 to 3 days) until bleeding is resolved or healing is achieved. Koate DVI 20 10 IU/kg May respond to a single dose. Repeat if ...
Betty L. Gahart, Adrienne R. Nazareno, 2015
5
Saunders Nursing Drug Handbook 2014 - Sayfa 70
Human: Hemofil M, Koate-DVI, Monarc-M, Monoclate-P. Recombinant: Advate, Hexilate FS, Kogenate FS, Recombinate, Refacto, Xyntha) uCLASSIFICATION PHARMACOTHERAPEUTIC: Antihemophilic agent. CLINICAL: Hemostatic.
Barbara B. Hodgson, Robert J. Kizior, 2013
6
Coagulation and Blood Transfusion: Proceedings of the ... - Sayfa 200
Our FVIII:Ag ELISA measures only the light chain of factor VIII, and possibly the batches of Hemofil M used had a relatively low content of factor VIII light chain. The results of FVIII:Ag determinations for the preparations diluted in hemophilia A ...
Cees Smit Sibinga, P.C. Das, P.M. Mannucci, 2012
7
Rossi's Principles of Transfusion Medicine
As many as 90% of hemophiliacs became seropositive to hepatitis B surface antigen.42 Because of this serious complication, in 1980 a Factor VIII concentrate (Hemofil T, Hyland Laboratories, Glendale, CA) was developed that was heated in ...
Toby L. Simon, Edward L. Snyder, Christopher P. Stowell, 2011
8
Scandinavian Journal of Haematology: Supplementum - Sayfa 170
Supplementum Margareta Blombäck. table s. Elimination half-life. Mean value, S D and range. TABLE 6. Half-lives after the administration of Hemofil, Travenol. nation half-life in 20 patients by least square regression analysis and with best ...
9
Catalog of Copyright Entries. Third Series: 1977: January-June
Hemofil factor 8 concentrate AHF dosage indicator. Hemofil factor 8 concentrate % increase indicator. Add. ti: Hyland, division of Travenol Laboratories, Inc. Hemofil dosage calculator. NH: compilation & additional text. 0 Perrygraf, division of ...
Library of Congress. Copyright Office, 1978
10
Pediatric Dosage Handbook: Including Neonatal Dosing, Drug ...
... (Human) (an tee hee moe FIL ik FAK tor HYU man) U.S. Brand Names Hemofil M, Koāte(R)-DVI, Monarc-M", Monoclate-P(8) Canadian Brand Names Hemofil M Index Terms AHF: AHG, Factor VIII Therapeutic Category Antihemophilic Agent; ...
Carol K. Taketomo, Jane Hurlburt Hodding, Donna M. Kraus, 2009
10 NACHRICHTEN, IN DENEN DER BEGRIFF «HEMOFIL» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
hemofil im Kontext der folgenden Nachrichten gebraucht wird.
Baxalta Expected to Post Earnings of $0.48 Per Share (NASDAQ …
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «WKRB News, Okt 15»
Baxalta Expected to Announce Earnings of $0.48 Per Share …
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Dakota Financial News, Okt 15»
Baxalta Receives "BBB+" Credit Rating (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Dakota Financial News, Okt 15»
$0.48 EPS Expected for Baxalta This Quarter (NASDAQ:BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Dakota Financial News, Sep 15»
Baxalta Earns BBB+ Credit Rating (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Mideast Time, Sep 15»
Baxalta Receives "BBB+" Credit Rating from Morningstar (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Dakota Financial News, Sep 15»
Baxalta Receives Average Rating of "Hold" from Analysts (NASDAQ …
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Financial Wisdom Works, Sep 15»
Morningstar Assigns "BBB+" Credit Rating to Baxalta (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Dakota Financial News, Sep 15»
Morningstar Gives "BBB+" Credit Rating to Baxalta (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «WKRB News, Sep 15»
Baxalta Earns BBB+ Credit Rating from Morningstar (BXLT)
The Company's products include ADVATE, RECOMBINATE, HEMOFIL M, Immunate, Immunine, PROTHROMPLEX TOTAL, RIXUBIS, FACTOR VII NF, BEBULIN ... «Financial Wisdom Works, Sep 15»
